On The Horizon

Blog Archives

Variables of prospective response rates of PD-1/PD-L1 based therapies across cancers

Posted on August 28, 2019 by by

thassodotcom Posted in Genetic Background, Genetic Predisposition, New Research, On The Horizon, Personalized Medicine, Thasso Post, Theragenomic Medicine No Comments ↓

…

The phenotype broker: Blockchain and patient phenotype

Posted on July 26, 2019 by by

thassodotcom Posted in New Research, On The Horizon, Personalized Medicine, Personomics, Targeted Therapy, Thasso Post, Theragenomic Medicine No Comments ↓

July 26, 2019 – “Blockchains for secure digitized medicine”. This is the title of a very interesting and important article in the Journal of Personalised Medine (JPM) as of May 28, 2019.

Blockchain as an emerging technology (particularly around the hype on Bitcoins) has been gaining in popularity,

…

Where portrait photos meet genetics and AI

Posted on June 13, 2019 by by

thassodotcom Posted in Clinical Development, Digital Health, Genetic Background, Genetic Predisposition, In The Press, Neue Forschung, On The Horizon, Thasso Post, Theragenomic Medicine No Comments ↓

June 13, 2019 – This is simply fascinating stuff. Researchers are testing neural networks that automatically combine portrait photos with genetic and phenotypic patient data in order to obtain definitive diagnosis of hereditary rare diseases, all with the help of artificial intelligence (AI).

…

New gene variants in depression

Posted on May 13, 2018 by by

thassodotcom Posted in Allelic Variant, Genetic Background, Genetic Predisposition, Genetic Susceptibility, New Research, On The Horizon, Thasso Post, Theragenomic Medicine No Comments ↓

May 13, 2018 – Researchers have uncovered 17 genetic variants linked to different depression-related phenotypes in a large genome-wide association study, including variants near genes involved in neurotransmission and synapse function.

The first author of the study, David Howard, Center for Clinical Brain Sciences, University of Edinburgh,

…

Tags: Allelic Variant, Depression, Depression-Related Phenotype, Genetic Variants, Thasso Post, Theragenomic Medicine, UK Biobank

Chinese arrhythmia in traditional medicine

Posted on May 4, 2018 by by

thassodotcom Posted in Adverse Drug Reaction [ADR], In The Press, New Research, On The Horizon, Personalized Medicine, Thasso Post, Theragenomic Medicine No Comments ↓

May 04, 2018 – All natural is healthy. This is a common belief for many, particularly when shopping for alternative medicines and dietary supplements. For many, however, the contrary might be fatally true.

As a point in case, new research shows, that substances in Traditional Chinese Medicine (TCM) can cause severe cardiac arrhythmia.

…

Placebo: A veritable treatment option

Posted on February 11, 2018 by by

thassodotcom Posted in Genetic Background, Genetic Predisposition, New Research, On The Horizon, Personalized Medicine, Placebo, Thasso Post, Theragenomic Medicine No Comments ↓

February 11, 2018 – Long after cancer treatment ends, many patients continue to deal with one particular symptom that refuses to go away: fatigue. In a new study, researchers have found that the power of placebos, even when fully disclosed to patients, might be harnessed to reduce fatigue in cancer survivors.

…

Placebomics: Where placebo and genetics meet

Posted on December 1, 2017 by by

thassodotcom Posted in Allelic Variant, Genetic Background, New Research, On The Horizon, Placebo, Thasso Post, Theragenomic Medicine No Comments ↓

December 01, 2017 – The placebome is a new game in town. That is where genetics and the placebo effect meet. The underlying discipline of study may well be “placebomics”, fitting genetics and the uniquely complex phenotype “Placebo Effect” into the -omics age of things.

…

Amish People: Old age because of genetic mutations?

Posted on November 20, 2017 by by

thassodotcom Posted in Allelic Variant, Genetic Background, New Research, On The Horizon, Thasso Post, Theragenomic Medicine No Comments ↓

November 20, 2017 – Thanks to old aged Amish people, the first ever anti-ageing genetic mutation(s) have been discovered. According to a study published in the Journal Science Advances revealed a research team from a Northwestern University Feinberg School of Medicine, Chicago, IL, USA that seemingly an Indiana Amish

community holds the (genetic) key to living about 10% longer.

…

Spinal Muscular Atrophy: Single-Dose Gene-Replacement Therapy

Posted on November 12, 2017 by by

thassodotcom Posted in Children, Gene Therapy, Genetic Background, Genetic Predisposition, New Research, On The Horizon, Thasso Post, Theragenomic Medicine No Comments ↓

November 12, 2017 – Spinal muscular atrophy type 1 (SMA1) is a progressive, monogenic motor neuron disease with an onset during infancy that results in failure to achieve motor milestones and in death or the need for mechanical ventilation by 2 years of age.

…

Theragenomic medicine: Accurate treatment response prediction in depressed patients

Posted on November 5, 2017 by by

thassodotcom Posted in New Research, On The Horizon, Personalized Medicine, Targeted Therapy, Thasso Post, Theragenomic Medicine No Comments ↓

November 05, 2017 – For some patients knowingly or not knowingly suffering from depression, the upcoming period of the year (i.e., the winter season in the Northern Hemisphere) with grey days and over-porportionally long nights, might be a difficult one. Should such patients enter a antidepressant treatment,

…